Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 11, 1994 - Issue 5
Submit an article Journal homepage
12
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Increased Risk of Secondary Leukemia After Single-Agent Treatment with Etoposide for Langerhans' Cell Hlstlocytosls

Riccardo Haupt Division of Pediatric Hematology/Oncology, G. Gaslini Children's Hospital, Genoa, Italy; Division of Cancer Etiology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
,
Thomas R. Fears Division of Cancer Etiology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
,
Paolo Rosso Department of Pediatrics, University of Turin, Turin, Italy
,
Roberto Colella Department of Pediatrics, University of Bari, Bari, Italy
,
Ciuseppe Loiacono Department of Pediatrics, University of Bari, Bari, Italy
,
Marino de Terlizzi Department of Pediatrics, University of Bari, Bari, Italy
,
Antonia Mancini Department of Pediatrics, University of Bologna, Bologna, Italy
,
Adele Comelli Division of Pediatric Hematology/Oncology, G. Gaslini Children's Hospital, Genoa, Italy
,
Paolo Indolfi Department of Pediatrics, University of Naples, Naples, Italy
,
Alberto Donfrancesco Department of Pediatric Hematology/Oncology, Bambin Gesù Hospital, Rome, Italy
,
Patrizia Operamolla Second Department of Pediatrics, University of Rome, Rome, Italy
,
Giuseppe Graria Department of Pediatrics, University of Bari, Bari, Italy
,
Adriana Ceci Department of Pediatrics, University of Bologna, Bologna, Italy
&
Margaret A. Tucker Division of Cancer Etiology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
 show all
Pages 499-507 | Received 19 Oct 1993, Accepted 31 Jan 1994, Published online: 09 Jul 2009

References

  • Ratain J, Kaminer L S, Bitran J. Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung. Blood 1987; 70: 1412–1417
  • Witlock J A, Greer J P, Lukens J N. Epipodophyllotoxin-related leukemia. Cancer 1991; 68: 600–604
  • Pedersen-Bjegaard J, Philip P, Pedersen N T. Acute nonlymphocytic leukemia, preleuke-mia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. Cancer 1984; 54: 452–462
  • Pedersen-Bjegaard J, Osterlind K, Hansen M, Philip P, Pedersen A G, Hansen H H. Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lung. Blood 1985; 6: 1393–1397
  • Pui C H, Ribeiro R C, Hancock M L. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991; 325: 1682–1687
  • Hawkins M M, Kinnier Wilson L M, Stovall M A. Epipodophyllotoxins, alkylating agents and radiation and risk of secondary leukemia after childhood cancer. Br Med J 1992; 304: 951–958
  • Nichols C R, Breeden E S, Loeherer P J, Williams S D, Einhorn L H. Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols. J Natl Cancer Inst 1993; 85: 36–40
  • Ceci A, De Terlizzi M, Colella R. Langerhans cell histiocytosis in childhood: results from the Italian cooperative AIEOP-CNR-HX 83 study. Med Pediatr Oncol 1993; 21: 259–264
  • Breslow N E, Day N E. Slatistical methods in cancer research. International Agency for Research on Cancer (IARC), Lyon 1987; 2, IARC scientific publication 82
  • Zanetti R, Crosignani P. Cancer in Italy, incidence data from cancer registries 1983–1987. Lega Italiana per la Lotta Contro i Tumori, TorinoItaly 1992
  • Haupt R, Comelli A, Rosanda C, Sessarego M, De Bernardi B. Acute myeloid leukemia after single-agent treatment with etoposide for Langerhans' cell histiocytosis of bone. Am J Pediatr Hematol Oncol 1993; 15: 255–257
  • Aricb M, Comelli A, Bossi G, Raiteri E, Piombo M, Egeler R M. Langerhans cell histiocytosis and acute leukemia: unusual association in two cases. Med Pediatr Oncol 1993; 21: 271–273
  • Henter J I. Elinder G, Lubeck PO, Ost A. Myelodysplastic syndrome following epipodophyllo-toxin therapy in familial hemophagocytic lymphohistiocytosis. Pediatr Hematol Oncol 1993; 10: 163–168
  • Smith M A, Rubinstein L, Cazenave L. Report of the Cancer Therapy Evaluation Program monitoring plan for secondary acute myeloid leukemia following treatment with epipodophyl-lotoxins. J Natl Cancer Inst 1993; 85: 554–558
  • Pedersen-Bjergaard J. Radiotherapy- and chemotherapy-induced myelodysplasia and acute myeloid leukemia. A review. Leuk Res 1992; 16: 61–65
  • Pedersen-Bjegaard J, Daugaard G, Hansen S T, Philip P, Larsen S O, Rorth M. Increased risk of myelodysplasia and leukemia after etoposide, cisplatin, and bleomycin for germ-cell tumors. Lancet 1991; 338: 359–363
  • Bajorin D F, Motzer R J, Rodriguez E, Murphy B, Bosl G J. Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy. J Natl Cancer Inst 1993; 85: 60–63
  • Gadner H, Heitger A, Grois N, Gatterer-Menz I, Ladish S. A treatment strategy for disseminated Langerhans' cell histiocytosis. Med Pediatr Oncol, in press
  • Pedersen-Bjergaard J, Philip P, Olesen Larsen S, Jensen G, Byrsting K. Chromosome aberrations and prognostic factors in therapy related myelodysplasia and acute nonlymphocytic leukemia. Blood 1990; 6: 1083–1091
  • Fourth International Workshop on Chromosomes in Leukemia. Secondary leukemias associated with neoplasia: treated and untreated. Cancer Genet Cytogenet 1982; 11: 319–321
  • Michels S, McKenna R, Arthur D, Brunning R. Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphological study of 65 cases. Blood 1985; 65: 1364–1372
  • Peng-Whang J, Young R, Lee E, Longo D, Schechter G, De Vita V. Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood 1988; 71: 403–414
  • Egeler R M, Neglia J P, Puccetti D M, Brennan C A, Nesbit M E. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer 1993; 71: 865–873

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.